AQDOT

About AQDOT

Aqdot is a UK-based chemistry company that originated from the University of Cambridge's Department of Chemistry. Founded in 2012 by Professor Chris Abell, Dr. Roger Coulston, and Dr. Jing Zhang, the company leverages patented technology developed within the university. The foundation of Aqdot's technology stems from the founders' research in supramolecular chemistry. This core technology, known as AqBit™, involves proprietary cucurbituril chemistry, which enables the creation of tiny droplets, or 'Aqdots', that can encapsulate, hold, and release materials under specific triggers like temperature, light, or pH changes.

The company operates with a dual business model. The Aqdot Solutions division collaborates directly with clients across various sectors to create bespoke applications for the AqBit™ technology. This partnership approach has led to developments in areas such as air quality improvement in transportation and targeted delivery of therapeutics. The second pillar is Aqdot Products, which develops and markets its own branded products. Notable among these is the Oderase range, a line of fragrance-free malodour elimination products for household use, which are sold directly to consumers online and through retail partners. Another product, AqStar™ M1, is positioned for formulators in the personal care and home care markets, serving business-to-business clients. Aqdot's revenue is generated through licensing its technology, direct product sales, and collaborative development projects with partners who can white-label the technology or create market-specific formulations.

Financially, Aqdot has secured significant backing from investors. In 2017, the company raised £5.3 million in a funding round led by IP Group plc. This followed a substantial £7 million Series A financing in 2015, which included investments from the University of Cambridge, Parkwalk Advisors, and IP Group. These capital infusions have been instrumental in advancing the company's research and development efforts and facilitating the commercialization of its technology platforms.